drugset / Trial / NCT04840849
Evaluate the Pharmacokinetics, Safety, and Tolerability of Nirsevimab in Healthy Chinese Adults
RandomizedParallel-groupTriple-blindOther
Summary
The purpose of this study is to evaluate the Pharmacokinetics, Safety, Tolerability of Nirsevimab in Healthy Chinese Adults.
Timeline
- Start
- 2021-06-22
- Primary completion
- 2021-11-18
- Completion
- 2021-11-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nirsevimab | Monoclonal antibody | — | Intramuscular |
Indications
No indication recorded.